Vitamin E as an antioxidant agent in CAPD patients

International Journal of Artificial Organs

Volumn 25, Issue 5, 2002, Pages 373-378

  Mydlik M ^a   Derzsiova K ^a   Racz O ^a   Sipulova A ^a   Boldizsar J ^a   Lovasova E ^a   Hribikova M ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

Antioxidant defense parameters; CAPD patients; Vitamin E

Indexed keywords

BLOOD; ENZYMES; NETWORK SECURITY; PATIENT TREATMENT; PLANTS (BOTANY);

ANTIOXIDANT DEFENCE; ANTIOXIDANT DEFENSE PARAMETER; ANTIOXIDANT SYSTEMS; ANTIOXIDANTS ENZYMES; CAPD PATIENT; CHRONIC RENAL FAILURE; MALONDIALDEHYDE; RENAL REPLACEMENT THERAPIES; SUPEROXIDE DISMUTASES; VITAMIN-E;

ANTIOXIDANTS;

ALBUMIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; DIALYSIS FLUID; ERYTHROCYTE ENZYME; ERYTHROPOIETIN; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; MALONALDEHYDE; PYRIDOXINE; RETINOL; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMATOCRIT; HOST RESISTANCE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SHORT COURSE THERAPY; SPECTROPHOTOMETRY; VITAMIN BLOOD LEVEL;

EID: 0036587329     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202500505     Document Type: Conference Paper

References (27)

1. Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 2000; 150: 217-24.
2. Ha TKK, Sattar N, Talwar D, et al. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. Q J Med 1996; 89: 765-9.
3. Nourooz-Zadeh J. Effect of dialysis on oxidative stress in uraemia. Redox Report 1999; 4: 17-22.
4. Pastor MC, Sierra C, Bonal J, Teixido J. Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis. Am J Nephrol 1993; 13: 238-43.
5. Maggi E, Bellazzi R, Falaschi F, et al. Enhanced LDL oxidation in uremic patients: And additional mechanism for accelerated atherosclerosis? Kidney Int 1994; 45: 876-83.
6. Halliwell B. How to characterize a biological antioxidant. Free Rad Res Commun 1990; 9: 1-32.
7. Taccone-Gallucci M, Giardini O, Lubrano R, et al. Red blood cell membrane lipid peroxidation in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 1986; 6: 92-5.
8. Taccone-Gallucci M, Casciani CU, Lubrano R, Giardini O. Vitamin E status in CAPD patients. Nephrol Dial Transplant 1989; 4: 75-6.
9. Bellazzi R, Maggi E, Bellomo G, et al: Low-density lipoprotein oxidation and antioxidized LDL antibodies in peritoneal dialysis patients. Adv Perit Dial 1993; 9: 312-7.
10. Mydlík M, Derziová K, Válek A, Szabó T, Dandár V, Takáč M. Vitamins and continuous ambulatory peritoneal dialysis (CAPD). Int Urol Nephrol 1985; 17: 281-6.
11. Pru C, Eaton J, Kjellstrand C. Vitamin C and hyperoxalemia in chronic hemodialysis patients. Nephron 1985; 39: 112-6.
12. Fitzgerald SP, Campbell JJ, Lamont JV. The establishment of reference ranges for selenium, the selenozenzyme glutathione peroxidase and the metalloenzyme superoxide dismutase in blood fractions. 5th International Symposium on Selenium in Biology and Medicine, Nashville, USA, 1992.
13. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
14. Lück H. Catalase. Spectrophotometric determinations. In: Bergmayer HU: Methods of enzymatic analysis. Ed. Chemistry Weinheim, 1962; pp. 885-8.
15. Yagi K. Assay for blood and serum. Methods Enzymol 1984; 105: 328-31.
16. Hansen L G, Warwicj W J. Laboratory suggestions. An improved method for serum vitamin A and E using fluorometry. Am J Clin Pathol 1978; 70: 922-3.
17. Hořeljší J, Fassati M, Jícha J. The Fundamentals of Chemical Investigation in Medicine (6th ed). Prague, Státní zdravotnícké nakladatelství, 1964; pp. 538-40.
18. Zíma T, Štípek S, Crkovská J, et al. Lipid peroxidation and antioxidant enzymes in CAPD patients. Ren Fail 1996; 18: 113-9.
19. Taylor JE, Scott N, Bridges A, Henderson IS, Stewart WK, Belch JJ. Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients. Perit Dial Int 1992; 12: 252-6.
20. Daschner M, Lenhartz H, Botticher D, et al. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 1996; 50: 1268-72.
21. Bonnefont-Rousselot D, Jaudon D, Jaudon MC, Issad B, et al. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 1399-405.
22. Girelli D, Lupo A, Trevisan MT, et al. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition, and antioxidant enzymes in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1992; 12: 205-10.
23. Canestrani F, Buoncristiani U, Galli F, et al. Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 1995; 234: 127-36.
24. Boran M, Küçükaksu C, Balk M, Çetin S. Red cell lipid peroxidation and antioxidant system in haemodialysed patients: Influence of recombinant human erythropoietin (r-HuEPO) treatment. Int Urol Nephrol 1998; 30: 507-12.
25. Friedrich W. Vitamins. Berlin-New York, Walter de Gruyter, 1988; pp. 1958.
26. Breborowicz A, Witowski J, Wieczorowska A, Martis L, Serkes KD, Oreopoulos DG. Toxicity of free radicals to mesothelial cells and peritoneal membrane. Nephron 1993; 65: 62-6.
27. Wieczorowska-Tobis K, Breborowicz A, Witowski J, Martis L, Oreopoulos DG. Effect of vitamin E on peroxidation and permeability of the peritoneum. J Physiol Pharmacol 1996; 47: 535-43.